International perspectives on the development, application, and evaluation of a multicancer early detection strategy.

Autor: Johnson SE; Union for International Cancer Control, Geneva, Switzerland., Jayasekar Zurn S; Union for International Cancer Control, Geneva, Switzerland., Anderson BO; Breast Health Global Initiative, Fred Hutchinson Cancer Research Center, Seattle, Washington., Vetter BN; Foundation for Innovative New Diagnostics, Geneva, Switzerland., Katz ZB; Clinton Health Access Initiative, Boston, Massachusetts., Milner DA Jr; American Society for Clinical Pathology, Chicago, Illinois.
Jazyk: angličtina
Zdroj: Cancer [Cancer] 2022 Feb 15; Vol. 128 Suppl 4, pp. 875-882.
DOI: 10.1002/cncr.33927
Abstrakt: The development and implementation of a multicancer early detection (MCED) test that is effective and affordable has the potential to change cancer care systems around the world. However, careful consideration is needed within the context of different health care settings (both low- and middle-income countries and high-income countries) to roll out an MCED test and promote equity in access.
(© 2022 American Cancer Society.)
Databáze: MEDLINE
Externí odkaz: